GTR Home > Tests > Search results - Lynch syndrome II

Apply filters

Showing test for 1 condition

reset

Compare labs

  • Hide states
More locations

GTR test search results for C1333991[DISCUI]

C Clinical test, R Research test

Showing 1 to 20 of 48 tests for 1 condition in 25 labs

CMLH1 Related Lynch Syndrome

Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

CColorectal cancer, hereditary nonpolyposis type 2

Lab: Centogene AG - the Rare Disease Company Rostock, Mecklenburg-Vorpommern, Germany
Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

CColorectal Cancer NextGen Sequencing (NGS) And Deletion/Duplication Panel

Lab: PreventionGenetics Marshfield, Wisconsin, United States
Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis
Total conditions (21)
Total targets (17)

CMLH1, MSH2. MLPA testing

Lab: Instituto de Medicina Genomica Paterna, Comunidad Valenciana, Spain
Test targets
Methods
  • D Deletion/duplication analysis

CHNPCC Comprehensive Panel - Sequence & Deletion/Duplication Analysis

Lab: Baylor Miraca Genetics Laboratories Houston, Texas, United States
Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

CPancreatic Cancer NextGen Sequencing (NGS) Panel

Lab: PreventionGenetics Marshfield, Wisconsin, United States
Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis
Total conditions (13)
Total targets (12)

CCancer NextGen Sequencing (NGS) Panel

Lab: PreventionGenetics Marshfield, Wisconsin, United States
Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis
Total conditions (43)
Total targets (35)

CRenal Cancer NextGen Sequencing Panel

Lab: PreventionGenetics Marshfield, Wisconsin, United States
Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis
Total conditions (25)
Total targets (18)

CLynch Syndrome NextGen Sequencing (NGS) and Deletion/Duplication Panel

Lab: PreventionGenetics Marshfield, Wisconsin, United States
Test targets
Methods
  • D Deletion/duplication analysis
  • E Sequence analysis of select exons
  • C Sequence analysis of the entire coding region
Total conditions (7)
Total targets (5)

CLynch Syndrome via the MLH1 Gene

Lab: PreventionGenetics Marshfield, Wisconsin, United States
Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

CLynch syndrome

Lab: Bioarray Elche, Comunidad Valenciana, Spain
Test targets
Methods
  • D Deletion/duplication analysis

CHereditary gynecologic cancers, high-risk panel

Lab: Invitae San Francisco, California, United States
Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
Total conditions (17)
Total targets (9)

CLynch Syndrome

Lab: Asper Biotech Asper Biotech Ltd. Tartu, Tartumaa, Estonia
Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

CMLH1

Lab: Fulgent Clinical Diagnostics Lab Fulgent Diagnostics Temple City, California, United States
Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

CRenal/Kidney NGS Panel

Lab: Fulgent Clinical Diagnostics Lab Fulgent Diagnostics Temple City, California, United States
Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
Total conditions (72)
Total targets (22)

CHereditary colon cancer

Lab: Invitae San Francisco, California, United States
Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
Total conditions (27)
Total targets (14)

CHereditary colon cancer, high-risk panel

Lab: Invitae San Francisco, California, United States
Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
Total conditions (16)
Total targets (7)

CHereditary breast and gynecologic cancers (Women's hereditary cancers)

Lab: Invitae San Francisco, California, United States
Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
Total conditions (28)
Total targets (22)

CHereditary cancer syndromes

Lab: Invitae San Francisco, California, United States
Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
Total conditions (61)
Total targets (34)

CHereditary pancreatic cancer

Lab: Invitae San Francisco, California, United States
Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
Total conditions (19)
Total targets (17)

Showing 1 to 20 of 48 tests for 1 condition in 25 labs

IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.